Home > Quotes > Ownership & Insider Trades > Individual Insiders

Insider Trades of BLAIR JAMES C Information

Click on the column header to resort 'ascending (^) or descending (v).

Individual Insider Trades

Company Relation Last Date Type Tran OwnerType Shares Traded Last Price Shares Held
ALIMERA SCIENCES INC Beneficial Owner (10%) 06/02/2011 Form 4 Disposition (Non Open Market) indirect 700,000 0 4,129,773
ALIMERA SCIENCES INC Beneficial Owner (10%) 06/02/2011 Form 4 Acquisition (Non Open Market) indirect 18,864 0 18,864
ALIMERA SCIENCES INC Beneficial Owner (10%) 06/02/2011 Form 4 Sell indirect 6,914 8.04 40,790
ZOGENIX, INC. Director 09/16/2011 Form 4 Buy indirect 3,500,000 2 9,923,335
CLOVIS ONCOLOGY, INC. Director 11/21/2011 Form 4 Acquisition (Non Open Market) indirect 2,110,267 0 2,074,879
CLOVIS ONCOLOGY, INC. Director 11/21/2011 Form 4 Buy indirect 931,683 13 2,990,937
OREXIGEN THERAPEUTICS, INC. Beneficial Owner (10%) 12/22/2011 Form 4 Buy indirect 469,147 1.45 2,967,415
REVA MEDICAL, INC. Beneficial Owner (10%) 03/23/2012 Form 4 Sell indirect 1,695,717 5.16 85,186
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 05/31/2012 Form 4 Disposition (Non Open Market) indirect 1,200,000 0 6,772,968
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 05/31/2012 Form 4 Acquisition (Non Open Market) indirect 93,434 0 93,434
DURATA THERAPEUTICS, INC. Beneficial Owner (10%) 07/24/2012 Form 4 Acquisition (Non Open Market) indirect 2,244,125 0 2,227,596
DURATA THERAPEUTICS, INC. Beneficial Owner (10%) 07/24/2012 Form 4 Buy indirect 784,313 9 3,006,132
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 01/18/2013 Form 4 Disposition (Non Open Market) indirect 1,000,000 0 5,772,968
ACHILLION PHARMACEUTICALS INC Beneficial Owner (10%) 01/18/2013 Form 4 Acquisition (Non Open Market) indirect 66,462 0 159,896

Create your free portfolio